<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 18 Mar 2021 21:21:49 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Science子刊：关键靶点Prosaposin浮出水面，动脉粥样硬化或迎来RNAi疗法！</title><link>https://mp.weixin.qq.com/s/fgQUYeWwinpr1g7V0igJKw</link><description></description><content:encoded><![CDATA[Science子刊：关键靶点Prosaposin浮出水面，动脉粥样硬化或迎来RNAi疗法！]]></content:encoded><pubDate>Thu, 18 Mar 2021 20:58:31 +0800</pubDate></item><item><title>抗击胰腺癌新疗法！穿透肽“运输”化疗药物深入肿瘤内部，小鼠生存率显著提升| Nature子刊</title><link>https://mp.weixin.qq.com/s/9V89A5wp4Cqz4EHl7iAing</link><description></description><content:encoded><![CDATA[抗击胰腺癌新疗法！穿透肽“运输”化疗药物深入肿瘤内部，小鼠生存率显著提升| Nature子刊]]></content:encoded><pubDate>Wed, 17 Mar 2021 21:00:20 +0800</pubDate></item><item><title>开发新一代CRISPR技术！Graphite Bio完成1.5亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/xVXjTqY7XmJ6mZQz6Uq6qg</link><description></description><content:encoded><![CDATA[开发新一代CRISPR技术！Graphite Bio完成1.5亿美元B轮融资]]></content:encoded><pubDate>Tue, 16 Mar 2021 20:58:54 +0800</pubDate></item><item><title>糖尿病治疗突破：GCGR抗体让胰岛α细胞变身β细胞，成功恢复胰岛素生产 | PNAS</title><link>https://mp.weixin.qq.com/s/6ehEmHvVR7m1x5a4160J9A</link><description></description><content:encoded><![CDATA[糖尿病治疗突破：GCGR抗体让胰岛α细胞变身β细胞，成功恢复胰岛素生产 | PNAS]]></content:encoded><pubDate>Mon, 15 Mar 2021 21:14:56 +0800</pubDate></item><item><title>拨云见日！首个阿尔茨海默症“声光”疗法II期结果积极：显著改善记忆、认知、脑萎缩</title><link>https://mp.weixin.qq.com/s/XtVmveoH-8rO7It8fZs6aA</link><description></description><content:encoded><![CDATA[拨云见日！首个阿尔茨海默症“声光”疗法II期结果积极：显著改善记忆、认知、脑萎缩]]></content:encoded><pubDate>Sun, 14 Mar 2021 21:00:59 +0800</pubDate></item><item><title>PD-1抗体“新搭档”：融合IL-21，抗肿瘤疗效大大提升 | Nature子刊</title><link>https://mp.weixin.qq.com/s/cJcaCt2qtcOoUt7RCegVaQ</link><description></description><content:encoded><![CDATA[PD-1抗体“新搭档”：融合IL-21，抗肿瘤疗效大大提升 | Nature子刊]]></content:encoded><pubDate>Sat, 13 Mar 2021 20:59:31 +0800</pubDate></item><item><title>蔡志坚点评 | 外泌体，掀起药物研发下一波热潮</title><link>https://mp.weixin.qq.com/s/GxnatLEWmoE2PLj6TfLmbQ</link><description></description><content:encoded><![CDATA[蔡志坚点评 | 外泌体，掀起药物研发下一波热潮]]></content:encoded><pubDate>Fri, 12 Mar 2021 20:58:32 +0800</pubDate></item><item><title>新型RNAi药物来了！有效穿透血脑屏障，促进肿瘤细胞死亡 | Science子刊突破成果</title><link>https://mp.weixin.qq.com/s/ukXbG3yTtvjDaH5yGiijdQ</link><description></description><content:encoded><![CDATA[新型RNAi药物来了！有效穿透血脑屏障，促进肿瘤细胞死亡 | Science子刊突破成果]]></content:encoded><pubDate>Thu, 11 Mar 2021 21:00:17 +0800</pubDate></item><item><title>2020年全球热门靶点新药市场格局</title><link>https://mp.weixin.qq.com/s/qPUMHudUafq-64JID0Zr-w</link><description></description><content:encoded><![CDATA[2020年全球热门靶点新药市场格局]]></content:encoded><pubDate>Wed, 10 Mar 2021 20:58:58 +0800</pubDate></item><item><title>准确率近90%，更早捕获皮肤癌，哈佛新型AI系统成功辅助诊断 | Science子刊</title><link>https://mp.weixin.qq.com/s/oLnAcCxXF2YDqCtn4xyV3Q</link><description></description><content:encoded><![CDATA[准确率近90%，更早捕获皮肤癌，哈佛新型AI系统成功辅助诊断 | Science子刊]]></content:encoded><pubDate>Tue, 09 Mar 2021 21:03:34 +0800</pubDate></item></channel></rss>